<DOC>
	<DOCNO>NCT01448538</DOCNO>
	<brief_summary>In research study observation patient wet age-related macular degeneration ( wet AMD ) perform . The term observational study indicate current course therapy associate circumstance record . In study , medical care change . Also , new drug test . This study conduct 30 center Germany . A total approximately 500 patient enrol . The study design period 12 month . At begin end study physician document patient data . Therefore use information patient record document visit . If information available study center , otherwise attend ophthalmologist consult vision acuity value visit observation period . Furthermore , patient ask participate three telephone interview fill visit study center short questionnaire current vision well-being . In telephone interview discuss patient wet AMD disease treatment , experience perspective well problem occur .</brief_summary>
	<brief_title>Non-Persistence/Non-Adherence ( NP/NA ) Wet Age-related Macular Degeneration ( wAMD ) Patients Germany</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Patient wet agerelated macular degeneration ( wAMD ) Patient already receive least one AntiVEGF injection From clinical standpoint , ophthalmological need treatment probable patient get additional antiVEGF injection next year . The patient able willing take part study ( answer short questionnaire study centre , 4 independent phone interview study period ) . At time inclusion visit , study centre exceptionally responsible treatment patient . The patient take part another study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Medication Non-Adherence</keyword>
	<keyword>Medication Persistence</keyword>
	<keyword>wet macular degeneration</keyword>
</DOC>